Targeted Dose Study of ATG in Haploidentical Hematopoietic Stem Cell Transplantation
Clinical trial NCT05166967 · COMPLETED
Trial details
- NCT number
- NCT05166967
- Sponsor
- Chinese PLA General Hospital
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-01
- Primary completion
- 2024-02-16
- Enrollment
- 204
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.